Niklas Mattsson-Carlgren
141 – 150 of 230
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
- Contribution to journal › Article
-
Mark
Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
- Contribution to journal › Article
-
Mark
Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease
- Contribution to journal › Article
-
Mark
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations
- Contribution to journal › Article
- 2020
-
Mark
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- Contribution to journal › Article
-
Mark
The implications of different approaches to define AT(N) in Alzheimer disease
- Contribution to journal › Article
-
Mark
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease from Other Neurodegenerative Disorders
- Contribution to journal › Article
-
Mark
The A4 study : β-amyloid and cognition in 4432 cognitively unimpaired adults
- Contribution to journal › Article
